A Phase II Study of Pembrolizumab (MK3475) with and without Bevacizumab

Clinical Trial Grant

Duke Scholars

Principal Investigator Katherine Barnett Peters Neurosurgery, Neuro-Oncology

Awarded By

Dana-Farber Cancer Institute

Start Date

June 1, 2015

End Date

May 31, 2019

Awarded By

Dana-Farber Cancer Institute

Start Date

June 1, 2015

End Date

May 31, 2019